DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Belotecan is an investigational drug.
There have been 7 clinical trials for Belotecan. The most recent clinical trial was a Phase 2 trial, which was initiated on January 1st 2009.
The most common disease conditions in clinical trials are Small Cell Lung Carcinoma, Lung Neoplasms, and Uterine Cervical Neoplasms. The leading clinical trial sponsors are Chong Kun Dang Pharmaceutical, Gachon University Gil Medical Center, and Yonsei University.
Recent Clinical Trials for Belotecan
|A Phase Ib/II Trial of Belotecan and Ifosfamide in Patients With Extensive Disease of Small Cell Lung Cancer||Gachon University Gil Medical Center||Phase 1/Phase 2|
|Belotecan Versus Topotecan for Recurrent Ovarian Cancer: A Randomized, Open-label, Parallel-group Phase IIb Trial||Chong Kun Dang Pharmaceutical||Phase 2|
|Study to Assess of Belotecan or Topotecan on Daily Schedule in Relapsed Small Cell Lung Cancer (SCLC) Patients||Chong Kun Dang Pharmaceutical||Phase 2|